CHESTPulmonary Vascular Disease

Pulmonary Vascular Disease

In brief: what’s new and notable in pulmonary vascular disease

Explore new and notable updates in pulmonary vascular disease, including research into predicting pulmonary hypertension in patients with COPD, venous thromboembolism in patients with COVID-19, and the influence cytokine patterns may have on survival in patients with pulmonary arterial hypertension (PAH). Get updates from the Networks in the CHEST Physician® publication, listen to podcasts on treating patients with PAH, and test your clinical knowledge with a fun sorting game in the Player Hub.

Pulmonary vascular disease resources for patients and clinicians

Clinician education resources to explore

Management of Acute Pulmonary Embolism: Pro/Con Debates

Management of Acute Pulmonary Embolism: Pro/Con Debates

Some aspects of treatment for acute pulmonary embolism remain controversial. Review pros and cons of each in this course.

Nurse in ICU

Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report

Review the latest update to CHEST’s guidelines for antithrombotic therapy and the prevention of thrombosis.

COPD Unmet Needs – The Patient Perspective

VTE Guidelines Detective

Practice your sleuthing skills by reviewing “evidence” for each patient to deduce the appropriate diagnosis and treatment strategy.

Patient education resources to share

A new diagnosis of PAH can be confusing and frightening for patients. Help them better understand their disease and what to expect from treatment with resources covering the symptoms, therapies, and risk factors for PAH and busting common myths surrounding living with this disease. Plus, a comprehensive patient guide offers an in-depth look into every aspect of PAH, from diagnosis to treatment and long-term management.



Pulmonary vascular disease news and notes

Follow the latest pulmonary vascular disease news


Restoration of RV function in PAH: Is it the holy grail to improve mortality and long-term outcomes?
Read this review of recent research into the efficacy of techniques for improving mean pulmonary arterial pressure (mPAP) and the effects mPAP has on patient outcomes.


Should therapeutic heparin be administered to acutely-ill hospitalized patients with COVID-19
Hear the authors of a recent article published in the journal CHEST debate the potential benefits and risks of administering therapeutic heparin to patients with COVID-19.


When Is It Not PAH?
Review how to distinguish between patients with PAH and those with heart or lung disease that presents similarly to PAH.


Addressing racial bias in pulse oximetry
Research suggests that pulse oximeters do not accurately measure blood oxygen levels in Black patients. Review data highlighting this issue and recommendations for ensuring effective care for all patients.


Targeted temperature management (TTM) after cardiac arrest: How cool?
Enhance your understanding of targeted temperature management in this review from Section Member-at-Large, Fiore Mastroianni, MD.


COVID Beyond the ICU: Management of Post-COVID-19 Pulmonary Disease
Review the signs and symptoms of post-COVID-19 pulmonary disease, tools for evaluation, and emerging data on management strategies.

Join the Community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.